Home Tags Cascade

Tag: Cascade

Phase III CASCADE Clinical Trial of Vadastuximab Talirine in Frontline Acute...

Earlier today, Seattle Genetics confirmed that it discontinued the phase III CASCADE clinical trial of vadastuximab talirine (SGN-CD33A) in frontline older acute myeloid leukemia...

Vadastuximab Talirine is Well-Tolerated with Rapid, High Remission Rates for AML...

Highlighted in three oral data presentations during the 58th annual meeting of the American Society of Hematology, being held in San Diego, CA, December...

Pivotal Trial with Vadastuximab Talirine Initiated for Treatment of Patients with...

A phase III study called CASCADE, designed to evaluate Seattle Genetics' vadastuximab talirine (SGN-CD33A; 33A) in combination with azacitidine (Vidaza) or decitabine (Dacogen) has...

FEATURED RESOURCES